Back to search

Article

Preliminary Findings from an Augmented Reality (AR) App Delivering Recovery-Oriented Cognitive Therapy for Negative Symptoms in Schizophrenia

2024-10-29

Abstract excerpt

<h4>Background</h4> Negative symptoms are a primary driver of poor outcomes in schizophrenia spectrum disorders (SSD), but there are no FDA-approved medications or FDA-cleared therapeutics targeting negative symptoms in schizophrenia. NST-SPARK is a novel digital therapeutic targeting negative symptoms in SSD. It is a smartphone application delivering recovery-oriented cognitive therapy (CT-R), via gamified augme...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d4c4246a-3057-5f55-8d6d-4735472afd1b
DOI
10.1101/2024.10.28.24315453
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Preliminary Findings from an Augmented Reality (AR) App Delivering Recovery-Oriented Cognitive Therapy for Negative Symptoms in SchizophreniaDOI 10.1101/2024.10.28.24315453
Select a neighboring publication to make it the new centre.